Matthew Saybolt, MD
Interventional Cardiology · Eatontown, NJNPI 1841519709
Payments from drug & device makers
Across 985 payments — averaging $681.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$203K
- Boston Scientific$137K
- Abbott$109K
- CSL Behring$95K
- Medtronic$80K
- Shockwave Medical, Inc$31K
- plus $15K from 31 others
Across 1 payment — averaging $1487.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 92 | $203,261 |
| Boston Scientific | 218 | $136,668 |
| Abbott | 320 | $109,438 |
| CSL Behring | 70 | $95,428 |
| Medtronic(2 entities) | 121 | $79,942 |
| Shockwave Medical, Inc | 49 | $30,556 |
| W. L. Gore & Associates, Inc. | 2 | $12,019 |
| Abiomed | 18 | $1,007 |
| Heartflow, Inc. | 3 | $285 |
| E.r. Squibb & Sons, L.L.C. | 12 | $236 |
| Cardiovascular Systems Inc. | 4 | $202 |
| Alnylam Pharmaceuticals Inc. | 3 | $187 |
| Cathworks, Inc. | 2 | $181 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $174 |
| Kestra Medical Technology Services, Inc. | 3 | $157 |
| Novartis | 9 | $152 |
| Pfizer | 9 | $146 |
| Johnson & Johnson | 2 | $81 |
| Kiniksa Pharmaceuticals International, PLC | 4 | $71 |
| Amgen | 4 | $68 |
| Boehringer Ingelheim | 4 | $61 |
| Portola Pharmaceuticals, LLC | 4 | $58 |
| Ancora Heart, Inc. | 2 | $43 |
| AstraZeneca | 3 | $41 |
| Cardinal Health 200 LLC | 2 | $38 |
| Bridgebio Pharma, Inc. | 2 | $34 |
| Sanofi-aventis U.S. LLC | 2 | $34 |
| Chiesi USA, Inc. | 2 | $28 |
| Biotronik Inc. | 1 | $28 |
| Novo Nordisk | 1 | $25 |
| Scpharmaceuticals Inc. | 1 | $24 |
| Procyrion, Inc. | 1 | $21 |
| Akcea Therapeutics, Inc. | 1 | $20 |
| Siemens Medical Solutions USA, Inc. | 1 | $19 |
| Merck | 1 | $19 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $16 |
| Cardiva Medical, Inc. | 1 | $16 |
How this compares
$670,784 in reported general payments places this provider in the 95th percentile of 166 interventional cardiology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Eatontown
- Daniel KissEatontown$172K
- Matt BachEatontown$83K
- Isaac TawfikEatontown$23K
- Dinesh SingalSomerset$1.4M
- Ankitkumar PatelGlen Ridge$717K
- Jaffar RazaSecaucus$537K
- Kintur SanghviBordentown$467K
- Ziad AbbudOcean$361K
- Ramin HastingsHasbrouck Heights$355K
- Ryan KapleHackensack$280K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.